Wu, Y., Burger, E., Bangum, M., Holmboe, F., Oteiza, F., Bugge, C., . . . Aas, E. (2024). HTA328 Role of Structured Expert Elicitation in Reimbursement Decisions: An Exploratory Case of Selpercatinib for Non-Small Cell Lung Cancer in Norway. Value in Health, 27(12), S419. https://doi.org/10.1016/j.jval.2024.10.2153
Chicago Style (17th ed.) CitationWu, Y., EA Burger, M. Bangum, F. Holmboe, F. Oteiza, C. Bugge, EM Sæther, and E. Aas. "HTA328 Role of Structured Expert Elicitation in Reimbursement Decisions: An Exploratory Case of Selpercatinib for Non-Small Cell Lung Cancer in Norway." Value in Health 27, no. 12 (2024): S419. https://doi.org/10.1016/j.jval.2024.10.2153.
MLA (9th ed.) CitationWu, Y., et al. "HTA328 Role of Structured Expert Elicitation in Reimbursement Decisions: An Exploratory Case of Selpercatinib for Non-Small Cell Lung Cancer in Norway." Value in Health, vol. 27, no. 12, 2024, p. S419, https://doi.org/10.1016/j.jval.2024.10.2153.